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As the global population and its demand for seafood increases more of our fish will come from 
aquaculture. Farmed Atlantic salmon are a global commodity and, as an oily fish, contain a rich source 
of the health promoting long-chain omega-3 fatty acids, eicosapentaenoic (EPA) and docosahexaenoic 
(DHA) acids. Replacing the traditional finite marine ingredients, fishmeal and fish oil, in farmed salmon 
diets with sustainable alternatives of terrestrial origin, devoid of EPA and DHA, presents a significant 
challenge for the aquaculture industry. By comparing the fatty acid composition of over 3,000 Scottish 
Atlantic salmon farmed between 2006 and 2015, we find that terrestrial fatty acids have significantly 
increased alongside a decrease in EPA and DHA levels. Consequently, the nutritional value of the 
final product is compromised requiring double portion sizes, as compared to 2006, in order to satisfy 
recommended EPA + DHA intake levels endorsed by health advisory organisations. Nevertheless, 
farmed Scottish salmon still delivers more EPA + DHA than most other fish species and all terrestrial 
livestock. Our findings highlight the global shortfall of EPA and DHA and the implications this has for 
the human consumer and examines the potential of microalgae and genetically modified crops as future 
sources of these important fatty acids.
Omega-3 (n-3) fatty acids are widely recognised as being essential nutrients for the health and well-being of 
humans, particularly with respect to the n-3 long-chain polyunsaturated fatty acids (LC-PUFA), eicosapentaenoic 
(EPA; 20:5n-3) and docosahexaenoic (DHA; 22:6n-3) acids, that exert a range of health benefits through their 
molecular, cellular and physiological actions1. Fish are the major dietary source of n-3 LC-PUFA for humans as 
well as being an excellent source of protein, vitamin and minerals2. Recommendations for the suggested daily 
intake levels of EPA and DHA vary globally, depending on the regional scientific or health advisory organisa-
tions3. Nevertheless, most agree that the general population should be consuming at least two portions of fish per 
week, one of which should be oily3–8. However, with the global population and its demand for seafood increasing 
coupled with wild catch fisheries at, or beyond, exploitable limits, a greater proportion of fish destined for the 
table market are being farmed. Indeed, aquaculture has been the fastest growing animal-food producing sector 
for the past few decades, outpacing population growth, and currently supplies around 50% of the world’s fish and 
seafood for human consumption9.
Atlantic salmon (Salmo salar L.) represents an increasingly popular species in the global fish market, largely 
due to its high market value over low-value freshwater species. Today, salmon farming occurs throughout the 
world, with the main producers being Norway, Chile, Scotland and North America with a combined produc-
tion volume of around 2 million metric tonnes10. Scottish salmon in particular is highly regarded throughout 
the world and has traditionally been marketed as a premium product, being the first fish and non-French food 
to receive the prestigious Label Rouge accolade in 1992 as well as being designated Protected Geographical 
Indication (PGI) by the European Commission in 200411–12. Accordingly, farmed Scottish salmon was the UK’s 
most exported food product in 2014 generating an export value of around £500 million GBP (~$789M USD) with 
the USA, France and emerging markets in the Far East, namely China, being the main importers13. Despite the 
prospective role that aquaculture can play in feeding the ever-growing population, there is increasing concern 
over the impact that this fast-growing industry could have on wild fish stocks14–19.
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As an oily fish, Atlantic salmon provide a high nutritional content to consumers, especially with respect to 
EPA and DHA. However, like humans, salmon along with other coldwater marine species of fish are inefficient at 
converting the shorter-chain fatty acid, α -linolenic acid (ALA; 18:3n-3), into EPA and DHA, and must therefore 
obtain the n-3 LC-PUFA through the diet2,16,20. Farmed salmon were traditionally fed a diet with high levels of 
the marine ingredients, fish oil and fishmeal, derived from pelagic fisheries. The continued pressures on wild fish 
stocks as aquaculture production grows along with greater competition for LC-PUFA sources from the nutra-
ceutical and pharmaceutical industries have resulted in changes to aquaculture feed formulations. Terrestrial 
ingredients such as plant sources, mainly of oilseed origin, are increasingly used in salmon feeds without any 
detriment to fish health or growth21. Nevertheless, the fatty acid profiles of vegetable oils differ from those of fish 
oil, being richer in n-6 PUFA and devoid of n-3 LC-PUFA, resulting in changes to the fatty acid composition of 
farmed fish16,21–23. Consequently, the nutritional benefit to the final human consumer is lowered prompting the 
International Fish Meal and Fish Oil Organisation, the trade group representing the marine ingredients industry, 
to highlight their concerns over the declining levels of n-3 LC-PUFA in farmed salmon. Thus, we examined the 
changes in the fatty acid contents and compositions, particularly with respect to EPA and DHA, in the flesh of 
Scottish Atlantic salmon farmed between 2006 and 2015 and discuss the potential implications for the human 
consumer.
Results and Discussion
From marine- to plant-based feeds. The main nutritional issue for marine finfish aquaculture has been 
the sourcing of sustainable alternative ingredients to replace the finite and highly exploited marine resources, 
fish oil and fishmeal. The development of modern, sustainable feeds with increased use of terrestrial ingredients, 
mainly of oilseed origin, has had no major effect on salmon health or growth performance21 and has resulted 
in a concomitant decrease in the levels of undesirable contaminants (e.g. dioxins and PCBs) in salmon flesh24. 
Nonetheless, the change in dietary oil source presents a problem for the aquaculture industry as the fatty acid 
composition of fish muscle (flesh) reflects that of the diet20. Rapeseed oil is the most commonly utilised fish 
oil alternative in Europe, including Scotland, due to its favourable price and ready availability. However, while 
plant-based alternatives including rapeseed contain some types of n-3 fatty acids they lack the nutritionally ben-
eficial n-3 LC-PUFA, EPA and DHA, found almost exclusively in fish oil and other marine sources (see Table 1). 
Consequently, the use of rapeseed oil in aquafeeds has resulted in increased levels of ‘terrestrial’ fatty acids such 
as oleic (18:1n-9), linoleic (18:2n-6) and, to a lesser extent, α -linolenic (18:3n-3). This trend is evident in the fatty 
acid profiles of farmed Scottish salmon and is particularly noticeable from 2010 onwards when the levels of ‘ter-
restrial’ fatty acids showed a greater rate of change, doubling from 15%, 5% and 2% in 2010 to ~30%, 10% and 5% 
in 2015 (18:1n-9, 18:2n-6 and 18:3n-3, respectively), while the marine fatty acids, EPA and DHA, fell by approxi-
mately half (Fig. 1 and Supplementary Table 1). The increased inclusion level of plant ingredients in salmon feeds 
accelerated with increased fish oil prices from 2009 brought about by the growing demand for this finite resource. 
This has led to similar changes in salmon compositions to that in Scotland being reported in both the Norwegian 
and Tasmanian salmon industries25–26, reflecting the changes in salmonid feed formulations throughout the years.
Although production of the global fed aquaculture industry increased from 15 to 35 million tonnes over the 
period 2000–2012, the level of fish oil used within the same period remained static at around 800,000 metric 
tonnes per year7,27,28. Aquaculture currently uses around 75% of the global fish oil supply with 21% going towards 
direct human consumption27–28. The increasing demand from aquaculture and the nutraceutical and pharma-
ceutical industries, coupled with natural climatic events such as El Niño affecting both fish oil supply and prices, 
resulted in the salmonid industry, as the biggest user of fish oil (~60%), necessarily reducing the overall levels of 
marine ingredients in feeds. For instance, fish oil inclusion levels in Norwegian salmon feeds fell from 24% in 
1990 to 11% in 201325. Consequently, commercial aquafeeds have increasingly incorporated blends of vegetable 
and fish or other oils to meet the nutritional requirements of the fish whilst also relieving pressure on marine 
resources, albeit with some compromise of the nutritional benefit to the human consumer.
Potential consequences for the human consumer. The benefits of consuming n-3 LC-PUFA in the diet 
with respect to health and well-being are well known. Increasing the intake of EPA and DHA has been associated 
with a wide range of health-promoting roles such as in the development and function of neural and eye tissue, 
particularly in infants, as well as in reducing the risk of cardiovascular disease, inflammation, depression and 
other chronic conditions1,29–32. Farmed Atlantic salmon is often marketed for its health promoting properties, 
primarily its high n-3 LC-PUFA content. However, this benefit will decline as alternative ingredients, such as 
vegetable oils, replace fish oils in the feeds of salmon. For example, the greater use of vegetable ingredients in sal-
monid feeds has resulted in higher n-6 levels in farmed fish21–23,26, (see also Supplementary Table 1). Although n-6 
fatty acids such as linoleic acid (18:2n-6) are considered essential in the diet, there is already a very high intake in 
the human diet such that an imbalance of n-6/n-3 may affect the uptake and function of the more beneficial n-3 
LC-PUFA1,33.
Absolute contents of EPA and DHA in the flesh of farmed Scottish Atlantic salmon have fallen significantly 
in recent years, decreasing on average from 2.74 g in 2006 to 1.36 g per 100 g wet weight (ww) serving in 2015 
(Fig. 2). Nonetheless, this is still comparatively higher than the 1.02 g, 1.36 g and 1.00 g EPA + DHA per 100 g 
ww serving reported in Norwegian farmed salmon in 201134, 201225 and 201335 respectively. Although both the 
Scottish and Norwegian salmon farming industries are served by the same three main commercial feed producers, 
differences in feed formulations between countries exist. The Norwegian salmon industry for example appears to 
focus largely on sustainability and produces a narrow range of product specifications, all with decreased reliance 
on marine ingredients in favour of terrestrial alternatives25. In contrast, the Scottish salmon industry is more 
complex and bespoke catering for both the value and premium markets primarily driven by retailers, the former 
being variable in n-3 LC-PUFA content and the latter formulated to deliver a high level of n-3 LC-PUFA such 
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Terrestrial Marine
Rapeseed Soyabean Sunflower Linseed Borage Camelina Fish Oila Fish Oilb Algal Oilc Algal Oild
Fatty acid (% of total lipid)
 14:0 0.1 0.1 0.1 0.1 0.1 0.1 7.5 7.1 3.6 1.1
 16:0 4.7 11.4 6.1 5.2 11.0 5.1 18.0 13.8 37.9 16.1
 18:0 1.9 4.0 3.5 3.5 3.7 2.6 3.6 1.5 1.1 1.9
 20:0 0.6 0.4 0.3 0.1 0.2 1.6 0.2 0.2 0.1 0.4
 Total saturates1 7.7 16.5 10.7 9.1 15.1 9.9 29.9 23.6 44.1 20.2
 16:1n-7 0.2 0.1 0.1 0.1 0.2 0.1 8.9 5.9 0.2 0.1
 18:1n-9 62.4 27.4 28.2 18.7 16.1 17.4 7.7 9.7 0.5 26.9
 18:1n-7 3.1 1.8 0.8 0.7 0.7 1.1 3.1 2.0 0.3 0.4
 20:1n-9 1.3 0.3 0.2 0.2 4.0 14.2 1.1 11.6 – –
 22:1n-11 – – 0.1 – – – 0.9 17.3 – –
 22:1n-9 0.1 – – – 2.5 2.6 0.1 1.2- – –
 24:1n-9 0.4 – – – 1.6 0.5 0.4 0.8 0.3 0.4
 Total monoenes2 67.5 29.6 29.5 19.8 25.1 36.4 22.8 49.0 1.3 28.0
 18:2n-6 16.4 48.9 59.4 15.6 37.7 19.3 1.2 1.4 0.3 1.9
 18:3n-6 – – – – 21.7 – 0.3 0.2 0.1 –
 20:2n-6 0.1 – – – 0.2 1.5 0.1 0.2 – –
 20:4n-6 – – – – – 0.1 1.0 0.4 0.8 1.1
 22:5n-6 – – – – – – 0.4 0.1 7.4 1.0
 Total n-6 PUFA3 16.5 48.9 59.4 15.6 59.5 20.9 3.3 2.4 8.7 4.2
 18:3n-3 8.3 5.1 0.3 55.5 0.2 31.9 0.9 1.1 0.2 0.1
 18:4n-3 – – – – 0.1 – 3.2 3.4 0.3 0.1
 20:3n-3 – – – 0.1 – 1.0 0.1 0.1 – 0.1
 20:5n-3 (EPA) – – – – – – 18.8 8.4 0.8 16.5
 22:5n-3 – – – – – – 2.2 0.9 0.1 3.4
 22:6n-3 (DHA) – – – – – – 12.4 8.7 44.0 27.1
 Total n-3 PUFA4 8.3 5.1 0.3 55.5 0.3 32.9 38.2 23.5 45.9 47.7
 Total PUFA5 24.8 54.0 59.7 71.1 59.8 53.8 47.3 27.4 54.6 51.8
 n-3:n-6 0.5 0.1 <0.1 3.6 <0.1 1.6 11.6 9.8 5.3 11.4
Table 1. Examples of differences in fatty acid compositions of various oil sources of either terrestrial or 
marine origin. 1Includes 15:0, 22:0 and 24:0. 2Includes 16:1n-9, 17:1, 20:1n-11 and 20:1n-7. 3Includes 20:3n-6 
and 22:4n-6. 4Includes 20:4n-3. 5Includes 16:2, 16:3 and 16:4. aSouth American fish oil (e.g. anchovy). bNorthern 
hemisphere fish oil (e.g. herring). cDHA-rich Schizochytrium sp. algal oil. dEPA + DHA Schizochytrium sp. algal 
oil (DSM nutritional products).
Figure 1. Changes in the levels of fatty acids (% of total fatty acids), of either marine (- - -) or terrestrial 
origin (___), in the flesh of Scottish Atlantic salmon farmed between 2006–2015 (mean ± SD). Stacked 
lettering above data points are in the order of 18:1n-9, EPA, DHA, 18:2n-6 and 18:3n-3 respectively, and indicate 
significant differences (P < 0.05) between years for the same fatty acid (n = 106, 174, 247, 81, 85, 393, 212, 523, 
546 and 687 for 2006–2015 respectively).
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that one portion provides an adequate weekly intake for humans. This has resulted in a wide range of feeds being 
produced with formulation data difficult to access due to retailer confidentiality. This is clearly evident from the 
variation and ranges of the fatty acid composition and content data presented in Figs 1 and 2.
Public health bodies such as the UK’s Food Standards Agency (FSA) and the American Heart Association 
(AHA) currently advise consuming at least two portions of fish per week, of which one should be oily3–8. With 
EPA and DHA levels in farmed salmon decreasing, a more effective approach would be through the establishment 
of Dietary Reference Intake (DRI) levels. However, there is no general consensus among health and scientific 
organisations, with 51 National and International expert bodies all suggesting variable DRI levels according to 
an individual’s health status3. For example, the AHA has no recommended DRI levels for the ordinary consumer 
but suggests a daily intake of 1.0 g EPA + DHA for those individuals with established cardiovascular disease7–8. 
The European Food Safety Authority (EFSA) suggest that all adults should be consuming 250 mg EPA + DHA 
per day respectively through oily fish consumption36, whereas the International Society for the Study of Fatty 
Acids and Lipids (ISSFAL) recommends a minimum daily intake of 500 mg to reduce the risk of cardiovascular 
disease37. Based on a 130 g portion, as advised by EFSA38, one portion of farmed Scottish salmon in 2015 would 
more than satisfy the daily DRI levels mentioned above, providing 1.8 g EPA + DHA. Nevertheless, since fish and 
seafood are the major dietary source of EPA and DHA in the human diet and are generally limited to one to two 
meals per week, it may be more appropriate to express the DRI on a weekly basis. Thus, a single 130 g portion of 
Scottish salmon farmed in 2006 would have been adequate to meet the 3.5 g EPA + DHA weekly intake level set 
by ISSFAL, whereas in 2015 this would have required two portions (Fig. 3). However, it is important to highlight 
that while the present results relate to Scottish averages there will be salmon products which will require both 
larger or smaller portion sizes to meet the DRI, based on the levels of fish oil in their diets. Few retailers state the 
Figure 2. Levels of EPA + DHA (g.100 g−1) in farmed Scottish Atlantic salmon between 2006 and 2015. 
Median (—), mean (…), interquartile range (box) and 10th and 90th percentiles (whiskers) are presented. 
Significant differences (P < 0.05) between mean values are indicated by different lettering (n = 106, 174, 247, 81, 
85, 393, 212, 523, 546 and 687 for 2006–2015 respectively).
Figure 3. Number of portions required (mean ± SD) to obtain a weekly intake of 3.5 g EPA + DHA 
(ISSFAL, 2004)36, based on a 130 g serving37. Significant differences (P < 0.05) are indicated by different 
lettering (n = 106, 174, 247, 81, 85, 393, 212, 523, 546 and 687 for 2006–2015 respectively).
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EPA and DHA content on pre-packaged salmon products at present35, possibly due to the changing levels of fish 
oils in diets but also due to inter-pack variation as both lipid and fatty acid content can vary according to the type 
of cut consumed39–40.
Farmed versus wild. Aquaculture is often viewed in a less favourable perspective than some other farming 
sectors. One popular misconception among consumers is that farmed fish are inferior in terms of quality and 
nutritional content than wild fish. In reality, farmed fish have been found to contain as much or, in most instances, 
more grams of EPA + DHA per serving than their wild-caught counterparts6,35,38. Moreover, it is often quoted 
that farmed salmon contains more fat and is less healthy than wild salmon. Lipids (fat) supply approximately 
twice the amount of energy as either protein or carbohydrates. Farmed fish such as Atlantic salmon are often 
fed a high-energy (lipid) diet to ensure optimal growth rate while sparing the more expensive dietary protein 
for conversion into muscle protein20. The lipid content of Scottish Atlantic salmon farmed between 2006 and 
2015 remained largely consistent (~12–13%), although some significant differences were observed between years 
(Supplementary Table 1). Nonetheless, these values are within the range reported elsewhere for farmed Atlantic 
salmon from different regions25–26, as well as for farmed salmon products found in UK supermarkets35. Wild 
salmon are capable of accumulating similar lipid levels to farmed salmon41. However, the lipid content of wild 
fish varies according to its nutritional state, which is affected by season, food availability, species, age, sex and 
developmental or reproductive status20,42. The lower levels (~4%) generally reported for wild salmon relate to the 
time when they are caught, typically during their return migration to rivers to spawn when the large lipid deposits 
accumulated have been mobilised and depleted to support gonadal development as well as supply the energy 
expended during migration itself42.
The aforementioned difference in lipid content between wild and farmed fish greatly affects the nutritional 
content, although the overall n-3 LC-PUFA levels in the flesh are ultimately determined by the levels in the feed. 
Fatty acid profiles are often presented as a percentage of the total lipid. This often leads to a further misinterpreta-
tion made by consumers regarding the perceived higher n-3 LC-PUFA nutritional content of wild fish compared 
to their farmed equivalents. In 2006, farmed Scottish Atlantic salmon flesh contained a similar proportion of EPA 
and DHA in the total lipid of their flesh to wild salmon (~24%, Fig. 4), owing to a high inclusion level of fish oil 
in the diet resulting in a fatty acid profile similar to that of the natural diet. Conversely, by 2010 the proportion of 
EPA and DHA in flesh lipid had significantly fallen to 21.7% and by 2015 to 13.0% which, at first glance, would 
suggest that wild salmon are more nutritionally beneficial to the human consumer. However, when expressed 
in absolute terms, i.e. grams of EPA + DHA per 100 g ww serving, which takes into account the lipid content of 
the flesh we find that, despite the reduction in EPA and DHA levels due to the increased use of plant ingredients 
in salmon feeds, farmed Atlantic salmon still provide a significantly higher amount of EPA + DHA than wild 
salmon, yielding 2.75, 2.21 and 1.36 g per 100 g ww flesh for salmon farmed in 2006, 2010 and 2015 respectively, 
compared to 0.76 g per 100 g ww flesh for wild salmon (Fig. 4). Furthermore, despite the decrease in the levels, 
farmed Scottish salmon still delivers more EPA + DHA than most other fish species as well as all farmed terres-
trial livestock (Fig. 5). Nevertheless, if the continuing trend for the increased use of plant ingredients in salmon 
feeds endures then the risk of negating the beneficial effects from farmed salmon consumption will be realised.
Future sources of EPA and DHA. Fish oil is still the main dietary source of EPA and DHA in the human 
diet. It is estimated that the annual demand for n-3 LC-PUFA to supply the global population of seven billion with 
500 mg EPA + DHA per day, as recommended by ISSFAL37, is 1.25 million metric tonnes which is far greater than 
the estimated current total supply from all sources of just over 0.8 million metric tonnes2,43. Therefore, there is a 
major chronic shortfall in EPA and DHA to supply human requirements and demand. The aquaculture industry 
has employed several strategies to reduce fish oil use while maintaining the nutritional benefits of farmed salmon 
consumption. This not only includes the blending of fish and vegetable oils in commercial feeds as previously 
Figure 4. Differences in the proportions (% of total fatty acids) and absolute levels (g.100 g−1) of 
EPA + DHA fatty acids between wild (Pacific species) and farmed Scottish Atlantic salmon from 2006, 
2010 and 2014 (mean ± SD). Bars bearing different lettering indicate significant differences (P < 0.05) (n = 21 
for wild salmon and 106, 85 and 687 for Scottish Atlantic salmon farmed in 2006, 2010 and 2015 respectively). 
Stacked bars represent contribution of EPA and DHA to total values for comparative purposes.
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mentioned but also extends to the use of finisher feeds, whereby fish are fed a plant-based diet for the major 
duration of the ongrowing production cycle before switching to a fish-oil diet in the final weeks prior to harvest 
to increase the content of beneficial n-3 LC-PUFA21–23. However, this method still relies upon the inclusion of 
fish oil in the feeds.
In the marine environment, microalgae are the primary producers of n-3 LC-PUFA that are subsequently 
consumed and accumulated through the food chain to give the high levels of EPA and DHA that we generally 
find in marine, especially oily, fish. Therefore, microalgae represent potential feedstock for food and feed. Indeed, 
algal products are already used in human nutrition, particularly in the infant formula market, with 75% of the 
production volume used in the health food market as dietary supplements44. Accordingly, microalgae have been 
investigated as a promising alternative to the traditional marine derived ingredients in fish feeds, although these 
have largely been limited to DHA-producing species45–46. The main production of n-3 LC-PUFA by microalgae 
has predominantly focussed on heterotrophic species (e.g. Schizochytrium, Crypthecodinium and Ulkena spe-
cies) that are cultivated by fermentation similar to yeasts under controlled conditions that give a higher produc-
tion efficiency44. However, this technology is still regarded as being in the development stage resulting in low 
production volumes and higher costs44 which, at present, are far more expensive than for fish oil and meal45. 
Nevertheless, the main issues concerning the industry with respect to increasing the scale of production while 
simultaneously decreasing the production cost are expected to be addressed within the next few years44. Thus, 
in the future, microalgae will likely become available as a feed ingredient although, at present, they are unlikely 
to fulfil aquaculture demands for n-3 LC-PUFA. Further alternative marine sources of n-3 LC-PUFA include 
the use of krill47 or calanoid copepods48, although again production volumes are expected to be low and there is 
concern over the possible effects that harvesting down the trophic chain may have on higher trophic species that 
are normally reliant on these zooplankton49.
Perhaps surprisingly, future de novo n-3 LC-PUFA sources may originate from land-based supplies. 
Genetically modified (GM) oilseed crops have been engineered to synthesise the n-3 LC-PUFA, EPA and DHA, 
not normally associated with plant sources. This involves inserting specific microalgae genes that encode for the 
biosynthetic enzymes required to produce these specific fatty acids to generate seeds that accumulate oils with 
up to 20% of total fatty acids as n-3 LC-PUFA50–51. These GM crops have been demonstrated to be an effective 
replacement for fish oil in salmon feeds43,52. Although there is currently no commercial production, the potential 
for production to increase rapidly means that in the near future volumes could be considerable, although chang-
ing public perceptions and attitudes towards GM products are required, particularly in some European coun-
tries, before these GM oils can be used on a commercial scale. Nonetheless, an n-3 LC-PUFA GM yeast strain is 
currently being used within the Chilean salmon industry to give a niche product53 although, as with microalgae 
production, the fermentation technology used to produce the yeast is currently expensive and unlikely to pro-
duce sufficient volumes to meet aquaculture demand in the near-future. However, both the microalgae and GM 
technologies offer clear potential to counter the global deficit of n-3 LC-PUFA sources and reverse the trend of 
decreasing levels of EPA and DHA in farmed fish and thus ensure that farmed Atlantic salmon will continue to 
maintain its nutritional benefit to the human consumer in the future.
Materials and Methods
Sample data. The present study examined over 3,000 fatty acid profiles of farmed Scottish salmon analysed 
between 2006 and 2015 by the Nutrition Analytical Service (NAS), Institute of Aquaculture, University of Stirling. 
Samples were provided year-round by a wide range of salmon producers and feed manufacturers, reflecting the 
Figure 5. Comparison between the levels of EPA + DHA (g.100 g−1) in Scottish farmed Atlantic salmon 
compared to other fish species (blue) and terrestrially (green) produced animals. Stacked bars for farmed 
Scottish Atlantic Salmon indicate the decline in EPA + DHA levels for 2006, 2010 and 2015 respectively. All 
samples are based on duplicate analysis and analysed in 2014/15, with exception to wild salmon (Pacific species, 
n = 21) and Scottish farmed Atlantic salmon (n = 106, 85 and 687 for 2006, 2010 and 2015 respectively). Refer 
to methodology for further information on species sampled.
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continual production of the Scottish salmon industry. All samples included in the study were deemed to be repre-
sentative of the commercial Scottish salmon industry, with trial fish, fish purchased from supermarkets or whose 
farmed location was otherwise unknown excluded from the study. The samples were processed by NAS in a lab-
oratory working towards ISO/IEC 17025 accreditation. Briefly, samples of standard quality cuts, a standardised 
muscle section used in flesh quality determination corresponding to the region of flesh between dorsal fin and 
anal fin, were shipped to NAS on ice and processed that day. All samples were skinned and boned before being 
thoroughly homogenised prior to analysis.
To compare the EPA and DHA levels (g.100 g−1 ww) in farmed Scottish salmon with other marine and ter-
restrial food products, samples of fresh Atlantic mackerel (Scomber scombrus) fillets, Atlantic cod (Gadus 
morhua) loin, tuna steak (Yellowfin tuna, Thunnus albacares), beef, chicken breast, lamb, macroalgae-fed lamb 
(North Ronaldsay, Orkney, Scotland) and pork meat, together with canned tuna in spring water (Skipjack tuna, 
Katsuwonus pelamis) and tinned sardines in spring water (Sardina pilchardus) were purchased from local retailers 
during late 2014/early 2015 and analysed as previously described. Wild salmon samples (n = 21), generally Pacific 
salmon species (Oncorhynchus kisutch, O. nerka or O. keta), were purchased from supermarkets between 2006 
and 2015 and analysed as described for farmed salmon. No differences in EPA + DHA content (g.100 g−1 ww) 
were observed between years, thus wild salmon samples were pooled.
Lipid and fatty acid determination. Total lipid was extracted from ~0.5 g of homogenised salmon flesh 
in 20 volumes of ice-cold chloroform/methanol (2:1 v/v) using an Ultra-Turrax tissue disruptor (Fisher Scientific, 
Loughborough, UK) and the lipid determined gravimetrically54. Fatty acid methyl esters (FAME) from total 
lipid were prepared by acid-catalysed transmethylation at 50 °C for 16 h55. FAME were extracted and purified 
as described previously56, and separated and quantified by gas-liquid chromatography using a Fisons GC-8160 
(Thermo Scientific, Milan, Italy) equipped with a 30 m × 0.32 mm i.d. × 0.25 μ m ZB-wax column (Phenomenex, 
Cheshire, UK), ‘on column’ injection and flame ionisation detection. Hydrogen was used as carrier gas with an 
initial oven thermal gradient from 50 °C to 150 °C at 40 °C.min−1 to a final temperature of 230 °C at 2 °C.min−1. 
Individual FAME were identified by comparison to known standards (Supelco™ 37-FAME mix; Sigma-Aldrich 
Ltd., Poole, UK) and published data56. Data were collected and processed using Chromcard for Windows (Version 
1.19; Thermoquest Italia S.p.A., Milan, Italy). Fatty acid content per g of tissue was calculated using heptadecanoic 
acid (17:0) as internal standard.
Statistical analysis. Statistical analyses were performed using Minitab® v.17.1.0 statistical software 
(Minitab Inc., PA, USA). Data were assessed for normality with Kolmogorov-Smirnov test and for homogeneity 
of variances by Bartlett’s test and examination of residual plots and, where necessary, transformed using arcsine 
or natural logarithm transformation. Data were compared by a one-way analysis of variance (ANOVA) with rep-
licate post hoc comparisons made using Tukey’s test57. A significance of P < 0.05 was applied to all statistical tests 
performed. Results are presented as mean ± standard deviation unless otherwise stated.
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